Used in research settings as a selective inhibitor targeting specific kinase pathways involved in inflammatory responses and cancer progression. Demonstrates potential in modulating cellular signaling to suppress tumor growth and reduce pro-inflammatory cytokine production. Investigated for its utility in preclinical models to evaluate therapeutic efficacy and mechanism of action in oncology and autoimmune disease contexts. Shows favorable pharmacokinetic properties in early-stage studies, supporting its use as a tool compound for target validation and pathway analysis.